1. Yang, Yuanxin, Zhang, Jian, Lv, Mingming, Yuan, Junying, Xu, Daichao. 2024. Defective prelamin A processing promotes unconventional necroptosis driven by nuclear RIPK1. In Nature cell biology, 26, 567-580. doi:10.1038/s41556-024-01374-2. https://pubmed.ncbi.nlm.nih.gov/38538837/
2. Suo, Jinlong, Shao, Rui, Yang, Ruici, Zheng, Xianyou, Zou, Weiguo. 2023. Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation. In Cell death & disease, 14, 336. doi:10.1038/s41419-023-05856-3. https://pubmed.ncbi.nlm.nih.gov/37217512/
3. Lee, Ju Hwa, Yoo, Nam Jin, Kim, Min Sung, An, Chang Hyeok, Lee, Sug Hyung. 2016. Mutational and expressional alterations of ZMPSTE24, DNA damage response-related gene, in gastric and colorectal cancers. In Pathology, research and practice, 212, 1113-1118. doi:10.1016/j.prp.2016.10.001. https://pubmed.ncbi.nlm.nih.gov/27729169/
4. Le Collen, Lauriane, Desgrouas, Camille, Lukas Croisier, Céline, Froguel, Philippe, Bonnefond, Amélie. . Rare ZMPSTE24 variants increase risk of hypertriglyceridemia and metabolic syndrome. In European journal of endocrinology, 192, 240-247. doi:10.1093/ejendo/lvaf031. https://pubmed.ncbi.nlm.nih.gov/39993161/
5. Barrowman, Jemima, Wiley, Patricia A, Hudon-Miller, Sarah E, Hrycyna, Christine A, Michaelis, Susan. 2012. Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. In Human molecular genetics, 21, 4084-93. doi:10.1093/hmg/dds233. https://pubmed.ncbi.nlm.nih.gov/22718200/